The 2nd Wellcome Trust Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities will once again bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging, and regulatory affairs.
The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. Methodological and regulatory aspects of biomarker identification and qualification across a wide spectrum of neurodevelopmental, neurodegenerative and neuropsychiatric diseases will be discussed including, autism, Parkinson's disease, Alzheimer’s disease, multiple sclerosis, and schizophrenia. There will also be a series of break-out sessions for in-depth discussion on the standardization of clinical biomarkers most likely to aid diagnosis and imaging-based studies in biomarker drug discovery. This meeting provides an opportunity for scientists from academia and the commercial sector to discuss the current state of the art in biomarkers and will aid future investment decisions in both sectors.
Abstract deadline: 10 December 2012